APA (7th ed.) Citation

M, S., S, U., B, S., CG, M., IK, P., & R, J. (2017). In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts. Dove Medical Press.

Chicago Style (17th ed.) Citation

M, Sreeranganathan, Uthaman S, Sarmento B, Mohan CG, Park IK, and Jayakumar R. In Vivo Evaluation of Cetuximab-conjugated Poly(γ-glutamic Acid)-docetaxel Nanomedicines in EGFR-overexpressing Gastric Cancer Xenografts. Dove Medical Press, 2017.

MLA (8th ed.) Citation

M, Sreeranganathan, et al. In Vivo Evaluation of Cetuximab-conjugated Poly(γ-glutamic Acid)-docetaxel Nanomedicines in EGFR-overexpressing Gastric Cancer Xenografts. Dove Medical Press, 2017.